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Abstract
This chapter presents some significant study cases on octocoral organisms (Eunicea
succinea, Eunicea mammosa, Eunicea knighti, Pseudoplexaura flagellosa, Eunicea laciniata,
Antillogorgia elisabethae,Muricea austera, Paragorgia sp., Lobophyton sp., Sarcophyton glaucum
and Sinularia lochmodes) that have been identified as a source of promising bioactive
compounds and whose results have further been used for studies on structure-activity
relationship (SAR) as a strategy to increase the value of the activity initially detected. The
scientific literature data discussed here were obtained with the SciFinder tool during the
period 2000–2016 and from the additional results here presented for the biofilm inhibition
activity of compounds and synthetic analogs for the cases related with Eunicea knighti and
Pseudoplexaura flagellosa (until now unpublished data of the authors of this chapter).
Keywords: bioprospecting, marine natural products, octocorals, structure-activity
relationship, synthetic and natural analogs, bioactivity
1. Introduction
Animals, plants and microorganisms of marine origin are suitable sources for the discovery
and development of numerous medicines and industrial products. Among the 36 animal phyla
described to date, 34 are represented in the marine environment, with about half being
exclusively marine [1, 2]. Such statistics demonstrate the immense potential of marine biodi-
versity from which only a small percentage has been studied as a source of compounds useful
to humans. The next few lines will briefly describe a very short history of marine natural
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products drug discovery, until today one of the major fields of application of marine natural
products (extensive reviews on the subject can be found in Refs. [3–8]).
Studies began in the early 1950s with the discovery of spongouridine and spongothymidine
isolated from the marine sponge Tehya crypta [9–11], natural compounds later transformed by
synthesis into vidarabine and cytarabine, respectively, and approved as drugs by the USA
Food and Drug Administration (FDA) [3]: vidarabine as an anticancer agent in 1969, and
cytarabine as an antiviral drug in 1976. Although the latter has recently been withdrawn from
the market, it is still being used in ophthalmic treatments. However, it was only in the mid-
1970s that the isolation of prostaglandins from octocoral species such as Plexaura homomalla
[12], the structural determination of several of them and their application in human medicine
encouraged many scientists to conduct research in this field. In such a way, by the end of the
last century, thousands of compounds had been isolated as major metabolites of conspicuous
marine organisms, easy to collect and easy to study.
Since then, thanks to tremendous efforts by scientists, to the improvement and easy access to
better techniques of collection of organisms (snorkeling, scuba, submersibles, remote operated
vehicles (ROVs)), to the discovery of modern techniques of chemical analysis and of biological
activity, to the emergence of the “omic” approaches (genomics, proteomics, metabolomics,
transcriptomics), to the recent genome mining approaches (exploitation of genome public
data) for the discovery of new natural products, and to the use of molecular biology in the
field of bioengineering, today approximately 25,000 bioactive marine compounds with novel
structure are known, many of them with potential industrial use [13]. Focusing only on the
pharmaceutical industry, 8 marine compounds approved by the FDA and/or by the European
Medicines Agency (EMEA) are on the market as therapeutic agents, 11 in different clinical
phases, 1458 in the preclinical phase (the data on the compounds in the clinical and preclinical
phases were taken as reported in recent references [3, 13, 14] and from A.M.S. Mayer’s website
in the USA (http://marinepharmacology.midwestern.edu, accessed: 2017-01-30). In addition,
there are many other compounds that remain in the laboratories of academic research groups
or research centers waiting for the opportunity and adequate funding to enter the commonly
so-called marine pharmaceutical pipeline, which allows them to start the path toward their
conversion to new drugs.
Furthermore, it is worth mentioning that in parallel with the aforementioned studies, toward
the first decade of the present century, numerous researchers turned their attention to look for
new sources of bioactives, that is, marine microorganisms (cyanobacteria, marine fungi and
other classes of Eubacteria) hoping to find new compounds and new activities, and because it
began to be known that many compounds previously isolated from macroorganisms were
actually produced by their associated microbes, as described in [4].
The aforementioned shows that marine organisms really are a fascinating source of molecules
with unique structures and exploitable biologic activity. The following are some of the com-
pounds of marine origin established in the market as therapeutic agents or used as industrial
products [3, 13, 14]: compounds used in cancer treatment such as cytarabine (CytosarU™,
Depocyt™) (mentioned above), trabectedina (Yondelis™), complex tetrahydroisoquinoline
alkaloid obtained from tunicate Ecteinascidia turbinata; Eribulin mesylate (Halaven™) isolated
from sponge Halichondria okadai; Brentuximav vedotin (Adcetris™) isolated from sea hare
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Dollabela auricularia and Plitidepsin (Aplidin™) isolated from ascidian Aplidium albicans which
last year received an orphan drug designation by EMA and by FDA; compounds used as
antivirals: vidarabin (Vira A™) (mentioned above), and the recent developed iota-
carrageenane (carragelose™) obtained from red algae (ready to enter the market); compounds
used to treat pain: ziconotide (Prial™) very powerful product, isolated from marine snail
Conus magnus ziconotide (Prial™); compounds used in hypertriglyceridemia treatment:
omega-3-acid ethyl esters (Lovaza®) and some other products such as the skin cream called
Resilience™whose active base is a crude extract of pseudopterosines and seco-pseudopterosines;
and although these ingredients ran their race as antiinflammatories, they were unsuccessful in
reaching the final stage; on the other hand, they retained their status as cosmeceutical products
of great demand for the care of sun-induced skin irritations.
Among marine organisms source of bioactives, octocorals—a sub-class of Anthozoa—are a
diverse group of colonial animals with 8 tentacle polyps and 8 internal mesenteries comprising
about 3000 species (1.5% of all marine animals) of soft corals, gorgonians (sea fans, sea whips),
sea pens and blue corals [15, 16] found throughout the world’s oceans. They have proven to be
a prolific source of natural products having new structures, many of them without terrestrial-
counterpart with relevant biological activities, which have been arising enormous interest both
in the academic world and in the industry in the last 50 years. The first publication on
octocorals came out in 1958 [17]. Since then, many studies on metabolites from octocorals have
been published in the chemical literature and biological activity and high-quality reviews have
appeared on the subject. Among such important contributions, it is worth mentioning the
article written by Coll in 1992 [18], the annual reviews initiated by Faulkner in 1984 until 2002
[6] and continued by Blunt and his New Zealand group since 2003 [7], as well as the reviews
by Rodríguez in 1995 [19], Berrue and Kerr in 2009 [20], Berrue et al. in 2011 [21], Almeida et al.
in 2014 [22], Hu et al. in 2015 [8] and by Lei et al. in 2016 [23]. According to all these published
data, the chemical constituents of octocorals are mostly steroids, acetogenins, sesquiterpenes
and numerous diterpenes (with at least 40 skeletal classes) and diterpenes glycosides (com-
pounds unique to gorgonians), exhibiting biological activities such as ichthyotoxic, antimicrobial,
anticancer or/and cytotoxic, antiviral, antiinflammatory, antiproliferative, feeding stimulation,
feeding deterrent, antipredatory, antifouling, antileishmanial, antiplasmodial and antiHIV-1,
among others.
All the studies mentioned above clearly show that the natural products from Cnidaria (mostly
corals) and from Porifera (mostly sponges) accounting for 56.89% of the total reported marine
bioactives [19] have become a very attractive source of study for scientists, with the added
value of being exploited industrially, particularly in pharmacology. However, for a compound
discovered in a laboratory to be transformed in an industrial product, it is first necessary to
maximize its biological activity and face the big problem of the sustainable supply (as men-
tioned in the literature [13]: whatever the use given to the compound, several grams to hundreds
of grams are required for preclinical development, multikilogram quantities are needed for clinical
phases and tons for industrial uses—figures that contrast with the minimum quantities isolated
commonly in the research laboratories).
These current problems are critical in the industrial development of natural products and have
lead to the development of new alternate ways such as preparation of synthetic or hemisynthetic
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analogs, among other applications, enhancing the activity and designing pharmacophores of
lower complexity that can then be synthesized by faster and easier routes.
For this reason, this chapter aims to show some studies of the scientific literature in the last
15 years, where octocorals emerge as an excellent source of bioactive compounds and how the
increase in their activity has been achieved through the use of the structure-activity relation-
ship (SAR) strategy. This method has become a powerful tool for the discovery of new bioac-
tive compounds and to promote the activity by converting bioactive compounds through
synthesis into chemical analogs. Furthermore, we will discuss how the preparation of analogs
could also be a way of helping the key current problem of material supply in a sustainable
manner. Finally, we will present some recent unpublished experimental data from our labora-
tory where the isolation of terpenoids and some of their natural homologs from octocorals, and
their conversion by chemical synthesis into compounds with higher biological activity have
been a good strategy to achieve the aforementioned purposes.
2. SAR study cases in octocorals (2000–2016)
The studies highlighted in this item show the results of the literature survey using the
SciFinder tool between 2000 and 2016, of some relevant studies reported, describing natural
analogs and semi-synthetic derivatives prepared as a strategy to promote biological activity of
compounds isolated from octocorals. The analyzed cases are chronologically organized
throughout the chapter and each SAR study appears in the chemical literature grouped under
subheadings with the name of the corresponding species. Figure 1 presents some of octocoral
species discussed here.
2.1. Eunicea succinea and Eunicea mammosa
Octocorals of the Eunicea genus are one of the most interesting gorgonians because they are a
source of abundant and diverse cembranoids and dolabellane diterpenoids, including some
glycosylated [20]. On the Scopus database, there are more than 56 search results of chemical
studies on Eunicea species. Biological activities described for cembranoids isolated from
Eunicea extracts include antiplasmodial, quorum sensing inhibition, antiviral and cytotoxic
activity against several cancer cell lines [20]. It has been described that cembranolides
containing cyclic ethers possess potent antileukemic activities [24], that is, euniolide 1, 12,13-
bisepieupalmerin 2 and eupalmerin acetate 3 cembranoids, isolated in large quantities from E.
succinea and E. mammosa, collected in shallow waters of Mona Island (Puerto Rico). These
natural compounds showed strong cytotoxic activity against several cell lines, being the oxy-
genated C-13 compounds (2 and 3) more active than the euniolide 1 [25].
In 2000, Puerto Rican scientists [25] synthesized a series of unusual analogs of natural
cembranolides 1–3 containing cyclic ether ring systems. They conducted some saponification
reactions using KOH from euniolide 1 to obtain eight derivatives, including the well-known
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crassin acetate; from compound 2 to obtain five derivatives and from compound 3 to obtain
four compounds. Natural compound 3 was also treated with CH2N2, Ac2O, photolysis,
ozonolysis and H2O2 to obtain 18 more derivatives. In this way, the authors obtained a large
variety of structural diverse diterpenoids with multiple oxygen bridges, nitrogen atoms and
hydroxyl groups. Finally, the 3 natural compounds together with 11 derivatives were tested in
the NCI-60 human tumor cell line screen. Natural compounds 1 and 2 had strong cytotoxic
activity (IC50 values of 0.1–43 μg/ml) while eupalmerin acetate 3 showed to be less active (IC50
values from 0.3 to 16 μg/mL). Unfortunately, the synthetic compounds screened were less
cytotoxic than the natural diterpenoids prototypes, only α-methylene-δ-lactones 4 and 5
obtained from 2 and 3, respectively, showed a characteristic pattern of differential cytotoxicity
and were approximately equipotent than the natural products from which they were obtained.
Figure 1. Some octocorals reviewed in this chapter in relation to the SAR studies of their active isolated metabolites.
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Cembranoids 12-epieunicin 6, 4-epijeunicin 7 and 13-epieupalmerin 8 were isolated from
gorgonian octocoral E. mammosa collected in Bahamas, and their structure and their anticancer
activity were determined [26]. Compounds 6 and 7 showed moderate cytotoxic activity with
A549 (human lung carcinoma), H116 (human colon carcinoma), PSN1 (human pancreatic
adenocarcinoma) and T98G (human caucasian glioblastoma); in contrast the activity of com-
pound 8 was higher (IC50 ranging from 0.5 to 5 μg/ml). In order to evaluate structure-activity
relationships, analogs 9–13 were prepared by chemical transformations of the natural com-
pounds and their activity were evaluated in the same mentioned assays. The chemical modifi-
cations introduced to the natural compounds potentiated the activity (excepting in compound
10), being the most active and selective compound 13 against A-549, H116 and PSNI. It is
noteworthy that synthetic analogs 11 and 13 exhibited greater potential than their parent
natural products. According to the mentioned results, it could be said that the introduction of
cyclic ether linkages across the cembrane skeleton enhances the activity, as well as the intro-
duction of an extra epoxide, that is, in compound 13, significantly increases the activity against
H116 and PSN1 (IC50 = 5 μg/ml in 8 to IC50 = 0.5 μg/ml in 13). These results suggest, as
mentioned by the authors of this study [26], that the analogs of this series appear to be
attractive targets for the development of antitumor agents.
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2.2. Eunicea laciniata
As there is not much published information about the antiviral activity of dolabellanes isolated
from soft corals, in 2014 Colombian and Brazilian researchers studied the dolabellanes
diterpenoids 13-keto-1(R),11(S)-dolabella-3(E),7(E),12(18)-triene (14) and β–araneosene (15)
for their antiviral properties. These diterpenoids were isolated in multigram scale from the
Caribbean octocoral E. laciniata collected at Santa Marta bay. The antiviral data showed that
they exhibited low antiHIV-1 activity and low toxicity. Supported by the fact that oxygenated
dolabellanes, isolated from brown algae, showed good antiviral activity [27, 28], the authors of
this article obtained derivatives 16–18 by epoxidation, by epoxide opening and by allylic
oxidation, respectively. These oxygenated compounds showed significant improvement in the
antiHIV-1 potency (100-fold) [29]. Their high antiviral activity, along with their low cytotoxic-
ity, makes them promising antiviral compounds, and is a good example of the usefulness of
this strategy to improve the biological activity of marine natural products. Currently, the
researchers are obtaining more oxygenated dolabellane derivatives in a continuous work to
improve the antiviral activity of natural dolabellanes.
2.3. Eunicea knighti and Pseudoplexaura flagellosa
In this section, we show our recent published results on quorum sensing inhibition (QSI) and
our until now unpublished biofilm inhibition data, related as antipathogenic activity of natural
compounds isolated from E. knighti and P. flagellosa and some of their synthetic analogs
prepared in our laboratory. However, first we would like to provide an introduction on
bacterial biofilms, quorum sensing inhibition and their relationship with the recently used
term antipathogenic activity.
Quorum sensing (QS) is defined as a phenomenon related to the gene expression of bacteria in
function of the density of their population, allowing the synchronization of phenotypes
through bacterial communication. Recently, quorum sensing has been recognized as one of
the main factors that regulates phenotypes such as bioluminescence, transfer of tumor-
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inducing plasmids (Ti plasmids), antibiotic production, swarming motility, biofilm maturation
(assembled bacterial communities that coordinate themselves for the expression of different
phenotypes that change over time and with the environment) and the production of virulence
factors [30]. Many bacteria do not express virulence factors until the population density is high
enough to overwhelm host defense and establish infection. Compounds with QS inhibitory
activity are capable of preventing bacterial communication and suppress some virulence
factors. These compounds have been termed as antipathogenic drugs [30]. Furthermore, some
QS inhibitor makes biofilms susceptible to antimicrobial treatments and can reduce mortality
and virulence in experimental models of infection. Thus, compounds with QSI and biofilm
inhibition activity can be considered as leads to antipathogenic drugs [30].
In the last 10 years, many researchers have focused their studies on marine metabolites, mainly
from octocorals [31], that exhibit antipathogenic activity, which involve, as mentioned, QSI and
biofilm inhibition activity. As previously described by Tello and colleagues in 2009, 2011 and
2012 [32–34], octocorals E. knighti and P. flagellosa collected in Santa Marta Bay (Colombian
Caribbean Sea) were extracted with organic solvents followed by fractionation on vacuum
column chromatography and reverse-phase HPLC to afford 16 pure compounds, and their
stereostructures were elucidated by means of spectroscopic features. Their activity as QS
inhibitors was evaluated against Chromobacterium violaceum (ATCC 31532)—a recognized bio-
sensor using a standard disk-diffusion assay, following the parameters described by Tello et al.
2012 [34] and 2013 [35]. Whatman filter paper disks (5.2 mm diameter) were initially sterilized
and then loaded with 2.5, 5.0, 7.5, 15.0 and 30.0 μg/disk of each compound. The disks were
placed on agar dishes plated with 100 μL of C. violaceum culture grown in trypticase soy broth
(106 cfu/mL, 0.5 Mac Farland) and finally the agar plates were incubated for 48 h at 26C. This
QSI assay is based on inhibition of QS pigment production (violet color) without interfering
with bacterial growth. Kojic acid was used as a positive control, as it is a known inhibitor of
quorum sensing systems [34, 35]. The biofilm inhibition assay was performed on polystyrene
multi-well plates (96 wells), the pre-inoculates of the bacterial strains Vibrio harveyi, Pseudomo-
nas aeruginosa and Staphylococcus aureus were grown in the Luria-Bertani (LB) culture medium
with an optical density (OD) of 0.2–0.3 A at 600 nm. All pure compounds were evaluated at
five different concentrations (0.5, 1.0, 2.5, 10.0 and 100.0 ppm). Finally, each well was filled with
LB culture medium up to 200 μL. Control of growth inhibition was monitored by measuring
the absorbance of each well at 621 nm before and after incubation as was described by Tello
and colleagues in 2013 [36]. Biofilm inhibitory activity is reported in Table 1, as IC50 (ppm).
Based on the results of QS inhibition (QSI) and biofilm inhibition, on their high amounts in the
gorgonians and on the diverse reactive functional groups present in their structures (e.g.
epoxide groups in the C-7 and C-8, hydroxy groups in the C-2 and C-18, reactive double bonds
between the C-3/C-4 and C-11/C-12, and keto or hydroxy reactive groups in C-3, C-6 and C-11)
six of the natural compounds were selected as lead compounds to improve their QSI activity
and to establish their biofilm inhibition activity via preparation of synthetic analogs using
regioselective, straightforward and reproducible reactions such as epoxide ring opening, oxi-
dations, treatment with iodine, photochemicals, methylation and acetylation, and synthesis of
cyclic hemiketals [35]. In total, we had in hand 50 cembranoids (natural and synthetic) which
were assayed for their QSI and biofilm inhibition activities. The results displayed in Table 1
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Assay Biofilm Inhibition IC50 (ppm)
a Quorum sensing Inhibitionb
(μg/disk)c
Compounds Pseudomonas
aeruginosa
Staphylococcus
aureus
Vibrio
harveyi
Chromobacterium violaceum
19 5.0 0.01 80.2 —
20 12.8 0.3 >100.0 —
21 52.9 15.7 7.8 —
22 3.7 1.8 5.8 2.5
23 23.8 11.7 17.3 5.0
24 56.1 2.2 >100.0 2.5
25 4.0 10.1 17.1 —
26 4.5 10.0 69.7 —
27 11.5 >100.0 11.0 7.5
28 17.2 >100.0 >100.0 —
29 9.2 20.9 0.3 —
30 6.4 1.0 >100.0 7.5
31 12.2 5.7 9.5 30.0
32 6.8 1.4 53.8 —
33 10.1 2.0 0.3 —
34 50.0 1.3 9.8 7.5
35 8.3 3.2 1.0 15.2
36 4.1 0.01 >100.0 —
37 9.3 0.8 >100.0 7.5
38 14.7 0.5 >100.0 —
39 52.3 3.2 21.4 7.5
40 37.4 0.13 34.5 —
41 57.3 0.04 1.2 7.5
42 21.6 1.3 16.8 7.5
43 49.8 35.5 >100.0 —
44 >100.0 >100.0 >100.0 —
45 >100.0 >100.0 >100.0 —
46 52.5 0.03 53.1 7.5
47 56.0 3.1 >100.0 7.5
48 >100.0 1.2 >100.0 —
49 >100.0 >100.0 >100.0 30.0
50 >100.0 0.8 >100.0 —
51 >100.0 8.5 >100.0 —
52 >100.0 0.6 >100.0 30.0
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estimate the correlation between QS and biofilm inhibition, demonstrating the potential
antipathogenic effect of the 50 cembranoids evaluated, as discussed below.
The results demonstrated that half of the synthetic tested cembranoid analogs showed QSI
activity without toxicity against the biosensor bacteria, results worth being highlighted, mainly
because 16 active synthetic analogs were obtained from 5 non-active natural compounds (in
QSI bioassay). The synthetic compounds with the best QSI activity were 22 (2.5 μg/disk),
23 (5.0 μg/disk) and 24 (2.5 μg/disk), presenting similar structure features, scilicet: C-7R
hydroxy methine group, a double bond with E configuration between C-8 and C-9, and an
acetyl group at C-18. The above allows us to infer that the presence of a E-hydroxy allylic
moiety is highly relevant for the activity [33]. It is worth noting that the three synthetic
Assay Biofilm Inhibition IC50 (ppm)
a Quorum sensing Inhibitionb
(μg/disk)c
Compounds Pseudomonas
aeruginosa
Staphylococcus
aureus
Vibrio
harveyi
Chromobacterium violaceum
53 47.2 0.01 6.2 7.5
54 46.2 0.02 62.5 30.0
55 51.4 0.07 14.5 30.0
56 >100.0 20.0 10.4 —
57 >100.0 81.5 >100.0 —
58 >100.0 >100.0 >100.0 —
59 33.6 3.1 38.3 —
60 28.5 0.3 2.6 —
61 43.5 4.2 52.5 —
62 >100.0 2.1 >100.0 —
63 >100.0 >100.0 >100.0 15.0
64 >100.0 >100.0 >100.0 7.5
65 >100.0 >100.0 >100.0 30.0
66 >100.0 >100.0 84.4 —
67 >100.0 >100.0 >100.0 7.5
68 >100.0 >100.0 >100.0 —
Kojic acid 17.2 24.7 >100.0 90.0
Solvent NI NI NI NI
aConcentration that inhibits 50% of the biofilm. ND, not determined; NI, no inhibition of biofilm.
bThe activity was measured taking into account the inhibition of the violet pigment.
cMinimum amount required in μg per disc of compound to inhibit the production of violet pigment. There is no inhibition
zone even at 30 μg per disk.
Table 1. IC50 of natural and synthetic analogs (50 cembranoids) in the bacterial biofilm and quorum sensing inhibition
assays.
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cembranoids (22, 23, and 24) were obtained from three natural inactive natural cembranoids
(19, 20 and 21, respectively). Finally, these compounds were not able to inhibit the C. violaceum
growth, thus, it suggests that inhibition on violacein pigment production is triggered by the
disruption of QS systems. Therefore, there is no selective pressure for the development of
resistance in bacteria.
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The biofilm inhibition results showed that half of the synthetic analogs inhibited the formation
of biofilm in the three bacterial strains used at concentrations lower than 100.0 ppm. It was
found that several compounds that did not exhibit QSI did not show inhibition of biofilm
formation either in the three biosensor strains evaluated, for example, compounds 44, 45, 58
and 68; however it was not a generalized trend. Otherwise, all compounds having QSI showed
inhibition of bacterial biofilm in at least one of the three strains used, except for compounds 49,
63–65 and 66. It was also evident that some of the synthetic analogs showed better biofilm
inhibition activity than their natural precursors used as leads (19–21, 25, 27 and 28), in several
cases achieving or increasing the activity. It was observed that most of the synthetic
cembranoid type analogs exhibited an excellent activity to inhibit the formation of biofilm
against Gram-positive S. aureus bacteria, although good results were also obtained against
Gram-negative bacteria P. aeruginosa and V. harveyi.
In particular, 9 synthetic analogs inhibited S. aureus bacteria at concentrations less than 1.0 ppm,
10 inhibited the same strain at concentrations between 1.0 and 10.0 ppm and 5 between 10.0 and
100.0 ppm (Table 1). The compounds that showed the best potency against this biosensor strain
were 40, 41, 46, 50, 52–54 and 60, out of which compounds 41 (0.04 ppm), 46 (0003 ppm), 53
(0.01 ppm), 54 (0.02 ppm) and 55 (0.07 ppm) were the most potent ones since they were up to
2000 times more active than the recognized kojic acid QS inhibitor, which presented an IC50 of
24.7 ppm. Against P. aeruginosa bacterium, only compound 22 (3.7 ppm) had a lower IC50 value
than kojic acid (17.2 ppm), but it is important to mention that 16 synthetic cembranoids analogs
had IC50 values between 10.0 and 100.0 ppm. Finally, four synthetic analogs (22, 41, 53 and 60)
were shown to be active at concentrations lower than 10.0 ppm against V. harveyi bacteria, being
compounds 41 and 60 the most active with IC50 values of 1.2 and 2.6 ppm, respectively. In
addition, 11 compounds had IC50 values between 10.0 and 100.0 ppm, being still more active
than the positive control used, which had an IC50 value greater than 100.0 ppm against this
biosensor strain. It is noteworthy that biofilm inhibition was achieved in all cases without
interruption of bacterial growth in the strains used, even at the highest concentration evaluated
(100.0 ppm). The fact that compounds 22, 24, 39, 41, 42, 46, 47, 51–54 showed biofilm and QSI
activity suggests that these compounds interfere in bacterial communication, preventing the
development or maturation of bacterial biofilm and successive development of bacterial commu-
nities, and therefore may serve as potential antibiotics.
It is worth highlighting that the comparison of the results of the bacterial biofilm inhibition
with the results found in the literature showed that the synthetic cembranoids analogs present
an excellent activity and low toxicity compared to other natural products reported, for exam-
ple, oroidin had an IC50 of 0.26 ppm against P. aeruginosa and an IC50 of 35.0 ppm against
Acinetobacter baumannii, dictiol C inhibited the formation of biofilm in the bacterial strain
Pseudoalteromonas sp. D41 at an IC50 of 9.2 ppm and finally agelasine D oxime showed an
MIC of 0.027 ppm against Staphylococcus epidermis. These IC50 values were higher than those
reported by us here for some of the synthetic analogs against the S. aureus biosensor bacteria,
for example, compound 41 (0.04 ppm), compound 46 (0.03 ppm), compound 53 (0.01 ppm),
compound 54 (0.02 ppm) and compound 55 (0.07 ppm) (Table 1).
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Some considerations about the structure-activity relationship of the compounds evaluated in
this bioassay must be taken into account, for example, the presence of an electronegative group
on C-7 (in most of the compounds “oxygen”) is highly relevant for the activity, since the most
active compounds presented this functionality. Also, the formation of a double bond with
E-configuration between carbons C-8 and C-9 is one of the most important rearrangements to
increase or induce biofilm inhibitory activity, since its absence or formation of the Z-isomer
decreases the activity, the presence of an electronegative group on C-2 and C-18 (oxygen)
enhances this activity, as can be observed in all active compounds in this bioassay, except for
compound 23. Finally, the formation of an exomethylene between carbons C-8 and C-19 also
has a positive effect on the activity, as can be seen in compounds 39 and 46.
In summary, six natural compounds were selected as lead compounds (19–21, 25, 27 and 28) in
an attempt to induce or enhance their antipathogenic activity by selectively applied chemical
transformations at different active sites of the cembrane nucleus. Thus, 33 analogs of
cembranoids (22–24, 39–68) were obtained, being half of them remarkably active in the QSI
bioassay against the C. violaceum biosensor strain and in the bacterial biofilm inhibition against
P. aeruginosa, S. aureus and V. harveyi strains, all without interfering the bacterial growth.
Finally, a select group of structurally related cembranoids (23, 23, 39–42, 46, 53–55) were
obtained as QS and bacterial biofilm inhibitors, making them excellent candidates to be used
as antipathogenic drugs by the pharmaceutical industry, since the relationship between biofilm
inhibitors and QS inhibitors is often associated with potent antipathogenic agents.
2.4. Antillogorgia elisabethae (Syn. Pseudopterogorgia elisabethae [37])
Pseudopterosins, seco-pseudopterosins and amphilectosins constitute an important class of
diterpene glycosides found in the gorgonian Antillogorgia elisabethae [37] (known before as
Pseudopterogorgia elisabethae), except for seco-pseudopterosins A-D isolated from
Pseudopterogorgia Kallo, collected from different regions of the Caribbean (Bahamas, Bermudas,
Florida, Providencia and San Andrés). The pseudopterosins were discovered first by Fenical
et al. in the late 1980s [38, 39] and since then numerous members of the scientific community
have been involved in this attractive area finding many other compounds of this kind, most of
them with potent biological activity [40, 41], that is, antiinflammatory and analgesic, wound
healing, antibacterial, anticancer, antiviral, antimalaria and antituberculosis, in in vitro and
in vivo assays with a new mechanism of action. Very recently, a protection of synaptic function
and potential as a neuromodulatory agent for PsA has also been reported [42]. In addition,
those compounds have demonstrated efficacy in Phase II clinical trials as an antiinflammatory
and wound healing agents and are the first commercial licensed natural product for use as an
additive in Estée Lauder skin care and cosmetic products. To date, 31 pseudopterosins, 11 seco-
pseudopterosins and 2 amphilectosins are known from nature. A recent review about this
topic can be consulted in [21].
We have had a special interest in pseudopterosins G, and P-U, 3-O-acetyl-PsU, seco-Ps J and
seco-Ps K isolated by Duque and collaborators [43–45] from specimens of P. elisabethae collected
at Providencia Island. After their isolation and chemical structure determination, we soon
discovered their high chemical diversity (natural analogs) and their potent therapeutic activity
[46–48] (antiinflammatory, cytotoxic and antimicrobial activity).
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Their antiinflammatory activity was evaluated by us using in vitro experiments as myeloperoxidase
(MPO) assay, nitric oxide release (cell-based assay) and scavenger activity on this radical [46].
Our results reported in [46] showed that compounds PsG, PsK, PsP, PsQ, PsS, PsT, PsU and
seco-PsK are promising molecules with an interesting and potent antiinflammatory activity. In
our experiments, they displayed more potent action than indomethacin, a clinical drug used
currently to treat inflammation and with different mechanism of action. Furthermore, the
results for the different MPO inhibition values obtained provided us with preliminary insights
toward their structure-activity relationship, that is, the activity depends on the kind of sugar
moiety, on whether sugar moiety is in a free form or acetylated, on the acetylation position
within the sugar moiety and on the glycosylation position. In addition, regarding the results of
NO release in J-774 cell-based assay, we found a greater activity for the pseudopterosins than
for the seco-pseudopterosins, clearly showing that the non-glycosylation improves the inhibi-
tion of NO release. And finally, by comparing the different NO inhibition values for individual
compounds, the inhibitory activity apparently depends on the glycosylation position, on the
stereochemistry of the aglycone and on the type of the skeleton. For example, the amphilectane
skeleton (PsP) has more inhibitory activity than the serrulatane skeleton (seco-PsK). However,
more experiments are needed in order to support structure-activity relationships among these
kinds of compounds.
The results of the cytotoxicity of the natural homologous compounds PsG, PsP, PsQ, PsS, PsT,
PsU, 3-O-acetyl-PsU, seco-PsJ and seco-PsK (69–77), evaluated using human cancer cell lines
(HeLa, PC-3, HCT116 and MCF-7) showed moderate and non-selectivity activity between the
lines used. After examining the mentioned cytotoxic activity results, it could be seen that some
SARs were evident. According to the results that we have published in [47], the position of
glycosylation on the terpene skeleton appears to affect the inhibitory activity profile, for
example, PsG (glycosylated in C-9 with fucopyranose) is more active than PsP (glycosylated
in C-10 with fucopyranose). Further, the type of sugar moiety also influences the activity, for
instance, PsP, which is glycosylated with fucopyranose, is more active than PsT, which is
glycosylated with arabinopyranose. Likewise, PsQ (C-40 mono-acetylated fucose as sugar
moiety) is more active than PsU (C-40 mono-acetylated arabinose as sugar moiety), and seco-
PsK (non-acetylated fucose as sugar moiety) is more active than seco-PsJ (mono-acetylated
arabinose as sugar moiety).
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Regarding the antimicrobial activity for the natural homologous 69–77, we found good and
selective activity against Gram-positive bacteria, Staphylococcus aureus and Enterobacter
faecalis, being the most active PsG, PsU, PsQ, PsS and seco-PsK. Additionally, they did not
show activity against the Gram-negative bacteria or the yeast used in our assay and, more
importantly, their antimicrobial potency was comparable to the reference drug vancomycin.
In examining our just mentioned data, published in [47], the following SARs could be noted:
fucopyranose glycosilation at C-9 instead at C-10 seems to increase the activity (PsG vs. PsP);
arabinopyranose instead of fucopyranose glycosilation favors the activity (PsT vs. PsP);
likewise, mono-acetylated arabinose as sugar moiety increases the activity (PsU vs. PsQ
and PsS (mono-acetylated fucose as sugar moiety)). In contrast, this behavior initially
observed in pseudopterosins is not consistent when the results are applied to the seco-
pseudopterosins seco-Psk (glycosilated with fucopyranose), which is more active than seco-
PsJ (glycosilated with arabinopyranose).
Additionally, it is important to mention that in our experiments published in Ref. [48], we
assayed pseudopterosins and seco-pseudopterosins (natural analogs 69–77) as antifouling
agents against marine bacteria isolated from heavily fouled marine surfaces. These compounds
at a 30 μg dose showed moderately to highly active against all Gram-positive microfouling
bacteria assayed, and non-active against the Gram-negative bacteria used. Tetracycline and
kanamycin reference antibiotics used in the assay showed similar values of activity with doses
of 30 μg as well. Furthermore, we performed assays of natural compounds 69–77, kanamycin
and tetracycline on bacterial growth and on biofilm disruption (% of inhibition) of Pseudomonas
putida IsoF used as a positive control for biofilm formation and of six marine bacterial strains
associated with fouled surfaces. The natural analogs tested showed no activity (did not inhibit
bacterial growth and did not promote biofilm formation) against Gram-negative bacteria
Pseudomonas putida Iso F, Alteromona Macleodii and Ochrobactrum pseudopgringonense strains 1
and 2. In contrast, they inhibited both growth and biofilm formation of Gram-positive bacteria
(Oceanobacillus iheyensis, Bacillus sp. and Kocuria sp.).
Finally, it is worth mentioning the many studies carried out using the chemical synthesis (total
synthesis and semi-synthesis) in order to increase the activity and to solve at least partly the
problem of the sustainable supply of pseudopterosins. Those studies were conducted by Broka
in 1988, Corey in 1989, 1990, 1998 and 2000, McCombie in 1990 and 1991, Buszek in 1995,
Schmalz in 1997, Kociensk in 2001, and Harroweven in 2004 (complete information on this
topic can be found cited and widely commented in Ref. [21]). Unfortunately, the mentioned
syntheses have not yet been used, perhaps due to the complexity or/and non-economically
ways of the synthetic routes applied. However, those efforts have provided information on
improvement of their biological activity, pharmacophore and mechanism of action. Moreover,
it is worth noting that semi-synthetic alkoxy or phenoxy substitution such as ether and acetate
derivatives of pseudopterosins are under patent protection [21].
At this point, we want to mention the recent studies reported in [40] where simplified synthetic
analogs of pseudopterosins 78–87 were prepared by Fenical and colleagues using a new and
efficient synthesis taking into account the following general structural modifications: degree of
substitution of the hexahydrophenalone core, different configurations at C-4 and at C-7, and
several sugar moieties and place of the glycosidation. Nine of the 10 compounds evaluated as
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racemic mixtures were active in the mouse-ear assay (the most active one was twice more
active than PsA) and no statistical differences were identified among compounds. Addition-
ally, the synthetic route involving only six steps leads to derivatives without substitutents at
C-1 and C-3 (reducing the number of stereoisomers) and allows for the preparation of
multigram amounts of them.
2.5. Muricea austera
Specimens of Muricea austera were collected in the Pacific coast of Panama during an expedition
of the Smithsonian Tropical Research Institute [49]. The MeOH extract of M. austera showed
in vitro activity against chloroquine-resistant Plasmodium falciparum. Bioassay-guided fraction-
ation using vacuum liquid chromatography followed by flash chromatography and normal-
phase HPLC purification yielded six compounds: three tyramine derivatives (88–90) and three
steroidal pregnane glycosides (91–93). The structures of the compounds were determined based
on their spectroscopic data. Several synthetic analogs were obtained under basic hydrolysis and
perbenzoylation reactions. All natural compounds and synthetic analogs were evaluated against
a drug-resistant Plasmodium falciparum and intracellular form of Trypanosoma cruzi.
Structure-Activity Relationship (SAR) Studies to Maximize the Activity of Compounds Isolated from Octocorals
http://dx.doi.org/10.5772/intechopen.74686
287
Natural compounds 88–92 showed moderate activity, being compounds 88 (IC50 36 μM), 89
(IC50 45 μM) and 90 (IC50 45 μM) the most active ones. The antiplasmodial activity of glyco-
sides 91 and 92 (IC50 67 and 80 μM) was increased in their peracetylated natural analog 99
(IC50 28 μM) [49]. Arabinopyranosides synthetic analogs 94 and 95 were also evaluated,
showing that perbenzoylated derivatives 94 (IC50 35 μM) and 95 (IC50 21 μM) were more
active against P. falciparum than natural compounds 91 and 92. The antiplasmodial activity of
analogs with stereochemistry as D-arabinopyranose 96 and 97 and D-galactosides 98 and 99
were also evaluated. Interestingly, compounds 96–98 displayed antiplasmodial activity, being
compound 98 (IC50 29 μM) the most active one, while perbenzoylated methyl β-D-galactoside
99 was inactive.
Given the antiplasmodial activity displayed by natural tyramine derivatives 88 (IC50 36 μM),
89 (IC50 45 μM) and 90 (IC50 38 μM), thirteen synthetic analogs were evaluated. The results
indicated that the derivatives with a fatty acid moiety 100 (IC50 72 μM), 101 (IC50 47 μM) and
102 (IC50 34 μM) showed similar activity to those of their natural analogs 88–90, suggesting
that the increasing of the number of carbons of the fatty acid chain produces an increase in the
activity, while the presence of polar groups decreases the activity as in compound 103 (IC50
62 μM). Finally, the presence of a bromine group on the tyramine aromatic ring as in 104 (IC50
17 μM) substantially enhances the antiplasmodial activity [49].
2.6. Paragorgia sp.
The octocoral genus Paragorgia has been barely studied; however, some diterpenoids and
steroids were reported in 1984 [50]. In 2008, Spanish researchers collected Paragorgia sp. by
bottom trawling near the Madagascar Island at a depth of 790 m. The sample was extracted
with isopropanol, and a bioguided isolation procedure allowed to isolate three novel cytotoxic
steroids derivatives named parathiosteroids A-C 105–107. The structures incorporate an
A-ring with different degrees of unsaturation, and a side chain containing both a thioester
and an acetamide groups. These structural novelties do not have precedents in marine natural
products chemistry [51]. Natural compounds 105–107 displayed cytotoxic properties against
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colon (HT-29), lung (A-549) and breast (MDA-MB-231) tumor cell lines with GI50 values in the
micromolar range. Interestingly, parathiosteroid B 106 showed a selective cytotoxicity against
HT-29 with a GI50 of 6.5 μM. Related compounds were detected in an aerobic degradation
study of bile acid cholate by a Pseudomonas sp. [52].
In addition the authors obtained by simple and fast synthesis in the laboratory, the three natural
products 105–107, starting from commercially available 20-(hydroxymethyl)-pregnan-1,4-dien-3-
one 108 and (+)-estrone 109. The synthesis includes oxidation of C-20 hydroxymethylene to
carboxylic acid followed by thioesterification of the carboxylic acid with N-acetylcysteamine.
The unsaturation pattern of A-ring at 106 was obtained by Birch reduction of 108 followed by
bromination at C-2 and subsequent dehydrohalogenation.
Furthermore, to obtain different synthetic analogs, the authors used XCH2CH2NHCOCH3
(X = O or NH) instead of sulfur derivate and prepared analogs with different oxidation
patterns at the A-ring. In this way, more than 20 steroids were prepared. These analogs were
assayed for their cytotoxic activity against HT-29, A-549 and MDA-MB-231 cell lines. Analog
110 showed to be more active than natural products (GI50 MDA-MB-231: 39 μM; A-549: 79 μM;
HT-29: 72 μM); this compound has no double bonds at A-ring and neither thioester at side chain.
Structure-activity relationship studies [51] showed that the presence of XCH2CH2NHCOCH3
moiety (X = S, O and N) in the side chain is essential for the antiproliferative activity, and that a
low oxidation degree on an A-ring results in a higher bioactivity.
2.7. Lobophytum sp.
Colonies of Lobophytum sp. collected in 2006 in Siladen (North Sulawesi, Indonesia) were
extracted with MeOH:CHCl3. The organic extract was chromatographed by MPLC and the
obtained fractions were further purified by analytical HPLC to obtain six cembranoids [53]. All
compounds were evaluated for cell growth inhibitory activity against three different cell lines:
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H9c2 (cardiacmyoblasts), C6 (glioma) and HeLa (epithelial carcinoma). One of the isolated
compounds, decaryiol D 111, showed a significant activity against C6 glioma cell line (IC50
40 μM) compared with the structurally related decaryiol B 112 which was inactive. This fact
indicated that the growth inhibitory activity of 111 should be attributed to the presence of the
hydroperoxy group in this molecule. Based on the availability of high amounts of decaryiol
113, it was subjected to several reactions (acetylations, oxidations and epoxidations) to obtain
six semi-synthetic derivatives with the purpose of extending the structure-activity relationship
knowledge.
The six synthetic cembranoids were also evaluated against the same cell lines and the results
showed that the derivative O-methyl decaryiol 114was more active against C6 glioma cell line
(IC50 of 8 μM) than the natural compound and it also presented a selectivity as it was inactive
against HeLa and practically inactive against the non-tumor H9c2 cell line [53]. These results
allowed to establish that minor structural changes on the cembranoid skeleton of decaryiol can
radically affect the activity and selectivity as cell growth inhibitors.
2.8. Sarcophyton glaucum
Sarcophine 115 is a bioactive cembranoid diterpenes with anticancer activity isolated by
Kashman group in 1974 [54, 55] from the Red Sea soft coral Sarcophyton glaucum. Continued
studies of structure-activity relationship as mentioned in Hassan et al., 2011 [56] suggested the
importance of functional groups at C-7/C-8 and the opening of the ring lactone to increase the
activity. In addition, later experiments confirmed the importance of macrocyclic double bonds
to the mentioned activity, and showed that bromination of sarcophine 115 improved the
antiproliferative activity against malignant breast cancer cells. Further experiments through
the oxidation of 115, which resulted in the formation of (+)-sarcophytoxin B exhibiting
antiproliferative activity, suggested that C-7/C-8 epoxide is not required for the activity. Thus
far, the reported studies clearly demonstrate the need to further optimize the epoxide func-
tionality of sarcophine in relation to its anticancer activity. Then, more experiments [56] were
done in the direction of measuring the activity of natural analogs 16-deoxysarcophine 116 and
2-epi-16-deoxysarcophine 117, and of compounds 118–129 prepared via etherification and
carbamoylation of 115 at C-7/C-8. The C-7 ether and carbamate functionalities can be taken as
different examples of the introduction of hydrogen bonding donor and hydrogen bonding
acceptor and π-aromatic groups at this position to examine their binding affinities toward their
molecule target. The analogs thus prepared were subjected to evaluation of their ability to
inhibit the proliferation and migration of the human metastatic prostate cancer PC-3 and
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breast cancer MDA-MB-231 cell lines using MTT and wound healing assays. Most analogs
exhibited enhance antimigration activity and lack of cytotoxicity toward the cancer cells.
2.9. Sinularia lochmodes
An interesting example related to the topic of this chapter is the one published by Tanaka et al. in
2013 [57]. This study mentions lectin SLL-2 isolated from octocoral Sinularia lochmodes as an
important mediator in the symbiotic relationship of this animal with its zooxanthellae (the symbi-
otic microalgae Symbiodinium) on which the coral depends for energy and nutrients. This lectin
SLL-2 influences the transformation of Symbiodinium cells into a non-flagellated coccoid form from
a flagellated-swimming form. In addition, Forssman antigen pentasaccharide GalNAcα(1,3)
GalNAcβ(1,3)Galα(1,4)Galβ(1,4)Glc 130 was also identified as a ligand of lectin SLL-2 [58]. The
authors, Tanaka et al. in [57], oriented their work in terms of structure-activity relationship. Thus,
the synthesis and biological evaluation of Forssman antigen pentasaccharide and some derivatives
obtained by using a one-pot glycosylation and polymer-assisted deprotection were assessed. For
the evaluation of the biological activity they used the analysis of the increase or decrease that occurs
when oligosaccharides (131, 132, 133 pentasaccharide derivatives of 130, protected with 2-
trimethylsilylethyl group at the reducing end and protected analogs 134–138) bind to the
fluorescent-labeled lectin SLL-2. The results revealed that the affinity of oligosaccharides for SLL-2
was dependent on the number of sugar units in the oligosaccharide and on the NHAc substituents
[57]. Modification of the GalNAc unit to a GaI unit reduced the binding affinity to SLL-2. These
results indicated that SLL-2 not only recognized the acetamide group at the non-reducing end of
the Forsmann antigen, but also the sugar units at the reducing end. In addition, α-GalNAc 138
showed a stronger affinity than that of β-GalNAc 137, comparable to that of tetrasaccharide 134.
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3. Conclusions
As we have shown throughout this chapter, there is no doubt that chemical synthesis plays an
important role in the bioprospection of chemical compounds isolated from octocorals, either in
the production of the bioactive natural product (supply a natural product), facilitating the
further ways of its development as a drug and its subsequent commercialization or in the
obtaining of a series of analogs that undoubtedly reveal important features on the interaction
of the bioactive molecule and its target, allowing the chemists of marine natural products to
change at convenience the activity and toxicity initially detected in the isolated compounds
and sometimes even to reach the establishment of the pharmacophore. However, it is also a
fact that this strategy has important limitations to consider, among them that the chemical
reactions used must be efficient, with the fewest possible steps, economical viable option, easy
to perform and to supply products with significant values of biological activity and without
by-side toxicity.
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The studies using the strategy analyzed in this chapter, suggest in most cases that the natural
compounds can be potential scaffolds for the design of potent bioactive leads against different
biological targets. In addition, the results indicate that a subtle structural change on the lead
compounds can dramatically affect the activity and the selectivity of the structure against the
different activities evaluated. The above corroborate that the assessment of the synthetic
analogs of this chapter appear to be attractive targets for the development of new anticancer,
antiinflammatory, antiviral, antimicrobial, antileishmanial, antiplasmodial and antipathogenic
agents. However, this strategy should be accompanied by in silico studies that allow to
establish the mechanisms of interaction between the proteins involved in the different biolog-
ical activities mentioned above with the substrates (natural and synthetic analogs), Thus, the
work will be carried out in a more effective way, translating into shorter times and in an
adequate investment of resources used in this strategy.
It is important to highlight in this section that for the case of the octocorals E. knighti and
P. flagellosa six natural compounds selected as lead compounds based on their activity values in
the QSI and biofilm inhibition assays and on the variety of reactive functional groups present
in their cembrane nucleus, selective chemical transformations were used with the purpose of
inducing or enhancing antipathogenic properties. As a result, 33 cembrane analogs were
obtained, half of them being remarkably more active than the naturals in the bioassays used,
without interfering with bacterial growth, which lead us to assume that the inhibition of the
phenotype expression is caused by disruption of the bacterial communication (QS) system. The
latter is noteworthy, because avoiding the bactericidal effect, there is no selective pressure in
the bacteria to develop resistance to this type of compounds.
As forA. elisabethae, the work shown above evidenced the importance of the pseudopterosins and
seco-pseudopterosins isolated from this octocoral collected in theNorth Caribbean Sea (Bahamas)
and in the South Caribbean Sea (Providencia Island), not only in relationship with their novel
chemical structure but also for their potent antiinflammatory, cytotoxic and selective antimicro-
bial activity against Gram-positive bacteria. The efforts of many well-known researchers using
the total synthesis of pseudopterosins and the SAR studies described by us in this chapter for
natural homologs, allow us to conclude that despite all the research done for about 30 years, the
development of these compounds as drugs or as active ingredients in cosmetic creams needs to be
continued. Particularly, the supply issue (currently the key point) needs the development of more
efficient and commercially viable syntheses or more SAR works aiming the elucidation of the
pharmacophore responsible for the activity. In relation to the latter, it is important to emphasize
that if we can determine the nature of the pharmacophore there would be no need to synthesize
the entire molecule but to achieve by synthesis a partial structure that retains the biological
activity, as tried by Fenical and coworkers [40] in their interesting work of the 2010 year.
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